ProGRP Is a more specific and sensitive tumour marker for SCLC In contrast to NSE and can be adopted as an adjunct diagnostic tool for SCLC, which Is worth promoting In a clinical setting. This evidence concerns the gene GRP and small cell lung carcinoma.